Gianmarco M. Giorgetti
Cagliari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.
Journal: Expert opinion on biological therapy
Published: February 27, 2023
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: September 08, 2022
The prevalence of celiac disease and the appropriateness of the diagnosis in family medicine setting could be lower than expected.
Journal: European review for medical and pharmacological sciences
Published: August 02, 2022
Faecalibacterium prausnitzii is not decreased in symptomatic uncomplicated diverticular disease of the colon.
Journal: Bioscience of microbiota, food and health
Published: June 21, 2022
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Journal: Inflammatory bowel diseases
Published: January 24, 2022
Clinical nutrition in internal medicine: An Italian survey by the scientific societies FADOI and SINPE.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: November 30, 2021
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients.
Journal: European journal of gastroenterology & hepatology
Published: March 20, 2021
Acute Diverticulitis Is at Significant Risk of Malnutrition: an Analysis of Hospitalized Patients in a Medicine Department.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: October 31, 2019
Assessment of nutritional status and therapy in emergency Medicine settings.
Journal: Journal of biological regulators and homeostatic agents
Published: December 22, 2018
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon: a pilot study.
Journal: Journal of biological regulators and homeostatic agents
Published: December 22, 2018
Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon.
Journal: Journal of clinical gastroenterology
Published: September 14, 2016
Last Updated: 09/26/2026